Alpna Tyagi

1.7k total citations
31 papers, 1.4k citations indexed

About

Alpna Tyagi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Alpna Tyagi has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Geriatrics and Gerontology. Recurrent topics in Alpna Tyagi's work include Silymarin and Mushroom Poisoning (13 papers), Sirtuins and Resveratrol in Medicine (7 papers) and Berberine and alkaloids research (6 papers). Alpna Tyagi is often cited by papers focused on Silymarin and Mushroom Poisoning (13 papers), Sirtuins and Resveratrol in Medicine (7 papers) and Berberine and alkaloids research (6 papers). Alpna Tyagi collaborates with scholars based in United States, India and Czechia. Alpna Tyagi's co-authors include Rajesh Agarwal, Chapla Agarwal, Rana P. Singh, Velmurugan Balaiya, Manjinder Kaur, Robert A. Sclafani, Komal Raina, Sunitha Siriwardana, Subbiah Pugazhenthi and Manjinder Kaur and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Alpna Tyagi

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alpna Tyagi United States	22	783	402	281	235	177	31	1.4k
Mallikarjuna Gu United States	19	695 0.9×	387 1.0×	191 0.7×	115 0.5×	44 0.2×	22	1.3k
Bhagavathi A. Narayanan United States	22	723 0.9×	116 0.3×	234 0.8×	152 0.6×	179 1.0×	31	1.7k
Bum Sang Shim South Korea	26	1.1k 1.4×	105 0.3×	193 0.7×	383 1.6×	82 0.5×	62	1.9k
Jeong‐Hyeon Ko South Korea	22	1.1k 1.5×	100 0.2×	167 0.6×	475 2.0×	271 1.5×	38	2.1k
Narayanan K. Narayanan United States	16	529 0.7×	99 0.2×	241 0.9×	107 0.5×	169 1.0×	22	1.2k
Pedro Michaluart Brazil	16	708 0.9×	72 0.2×	218 0.8×	278 1.2×	359 2.0×	19	1.7k
Khuloud Bajbouj United Arab Emirates	23	866 1.1×	200 0.5×	200 0.7×	375 1.6×	25 0.1×	66	1.8k
Do Young Lim United States	25	1.0k 1.3×	79 0.2×	231 0.8×	334 1.4×	44 0.2×	44	1.9k
Jarosław Paluszczak Poland	21	979 1.3×	86 0.2×	85 0.3×	152 0.6×	125 0.7×	52	1.5k
Shakir M. Saud United States	13	495 0.6×	166 0.4×	123 0.4×	163 0.7×	49 0.3×	15	1.0k

Countries citing papers authored by Alpna Tyagi

Since Specialization

Citations

This map shows the geographic impact of Alpna Tyagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpna Tyagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpna Tyagi more than expected).

Fields of papers citing papers by Alpna Tyagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpna Tyagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpna Tyagi. The network helps show where Alpna Tyagi may publish in the future.

Co-authorship network of co-authors of Alpna Tyagi

This figure shows the co-authorship network connecting the top 25 collaborators of Alpna Tyagi. A scholar is included among the top collaborators of Alpna Tyagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpna Tyagi. Alpna Tyagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tyagi, Alpna & Subbiah Pugazhenthi. (2023). A Promising Strategy to Treat Neurodegenerative Diseases by SIRT3 Activation. International Journal of Molecular Sciences. 24(2). 1615–1615. 19 indexed citations

Raju, Raghavan, et al.. (2023). Interactions of Cellular Energetic Gene Clusters in the Alzheimer’s Mouse Brain. Molecular Neurobiology. 61(1). 476–486.

Tyagi, Alpna, Musa Musa, Wladimir Labeikovsky, & Subbiah Pugazhenthi. (2022). Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome. Scientific Reports. 12(1). 19808–19808. 10 indexed citations

Tyagi, Alpna, et al.. (2020). Metabolic syndrome exacerbates amyloid pathology in a comorbid Alzheimer's mouse model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(10). 165849–165849. 21 indexed citations

Tyagi, Alpna, Thomas Chong, Cole R. Michel, et al.. (2018). SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain. Scientific Reports. 8(1). 17547–17547. 74 indexed citations

Shrotriya, Sangeeta, Alpna Tyagi, Gagan Deep, et al.. (2013). Grape seed extract and resveratrol prevent 4‐nitroquinoline 1‐oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses. Molecular Carcinogenesis. 54(4). 291–300. 35 indexed citations

Tyagi, Alpna, Komal Raina, Subhash Chander Gangar, et al.. (2013). Differential Effect of Grape Seed Extract against Human Non-small-Cell Lung Cancer Cells: The Role of Reactive Oxygen Species and Apoptosis Induction. Nutrition and Cancer. 65(sup1). 44–53. 21 indexed citations

Tyagi, Alpna, Komal Raina, Bettina Miller, et al.. (2013). Procyanidin B2 3,3^″-di-O-gallate, a Biologically Active Constituent of Grape Seed Extract, Induces Apoptosis in Human Prostate Cancer Cells Via Targeting NF-κB, Stat3, and AP1 Transcription Factors. Nutrition and Cancer. 66(4). 736–746. 31 indexed citations

Tyagi, Alpna, Chapla Agarwal, Lori D. Dwyer‐Nield, et al.. (2011). Silibinin modulates TNF‐α and IFN‐γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells. Molecular Carcinogenesis. 51(10). 832–842. 53 indexed citations

10.

Kaur, Manjinder, Alpna Tyagi, Rana P. Singh, et al.. (2011). Grape seed extract upregulates p21 (Cip1) through redox‐mediated activation of ERK1/2 and posttranscriptional regulation leading to cell cycle arrest in colon carcinoma HT29 cells. Molecular Carcinogenesis. 50(7). 553–562. 31 indexed citations

11.

Balaiya, Velmurugan, Subhash Chander Gangar, Manjinder Kaur, et al.. (2010). Silibinin Exerts Sustained Growth Suppressive Effect against Human Colon Carcinoma SW480 Xenograft by Targeting Multiple Signaling Molecules. Pharmaceutical Research. 27(10). 2085–2097. 41 indexed citations

12.

Kaur, Manjinder, Velmurugan Balaiya, Alpna Tyagi, et al.. (2010). Silibinin Suppresses Growth of Human Colorectal Carcinoma SW480 Cells in Culture and Xenograft through Down-regulation of β-Catenin-Dependent Signaling. Neoplasia. 12(5). 415–424. 98 indexed citations

13.

Tyagi, Alpna, Rana P. Singh, Kumaraguruparan Ramasamy, et al.. (2009). Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3. Cancer Prevention Research. 2(1). 74–83. 95 indexed citations

14.

Sclafani, Robert A., Sunitha Siriwardana, Barbara Frederick, et al.. (2009). Abstract #3989: Combined Resveratrol and radiation therapy in head and neck cancer. Cancer Research. 69. 3989–3989. 2 indexed citations

15.

Mateen, Samiha, Alpna Tyagi, Chapla Agarwal, Rana P. Singh, & Rajesh Agarwal. (2009). Silibinin inhibits human nonsmall cell lung cancer cell growth through cell‐cycle arrest by modulating expression and function of key cell‐cycle regulators. Molecular Carcinogenesis. 49(3). 247–258. 79 indexed citations

16.

Tyagi, Alpna, Yogesh Kumar Sharma, Chapla Agarwal, & Rajesh Agarwal. (2008). Silibinin Impairs Constitutively Active TGFα-EGFR Autocrine Loop in Advanced Human Prostate Carcinoma Cells. Pharmaceutical Research. 25(9). 2143–2150. 23 indexed citations

17.

Agarwal, Chapla, Alpna Tyagi, Manjinder Kaur, & Rajesh Agarwal. (2007). Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis. 28(7). 1463–1470. 107 indexed citations

18.

Tyagi, Alpna, Komal Raina, Rana P. Singh, et al.. (2007). Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine–induced urinary bladder carcinogenesis in male ICR mice. Molecular Cancer Therapeutics. 6(12). 3248–3255. 54 indexed citations

19.

Agarwal, Chapla, Alpna Tyagi, & Rajesh Agarwal. (2006). Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Molecular Cancer Therapeutics. 5(12). 3294–3302. 113 indexed citations

20.

Tyagi, Alpna, Rana P. Singh, Chapla Agarwal, et al.. (2005). Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR–Chk1/2–Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis. 26(11). 1978–1987. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact